Drug intelligence / Profile preview

Lipogud

Development stage: Unknown
Lead developer: Genspec Lifesciences
Modality: Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Oral

Overview

**Lipogud** is an oral liposomal iron-and-vitamin nutritional product marketed by Genspec Lifesciences. It contains liposomal ferric pyrophosphate with vitamin C, cyanocobalamin, and folic acid. The liposomal ferric pyrophosphate provides bioavailable iron to support hemoglobin synthesis and iron repletion; vitamin C supports intestinal iron absorption, while folic acid and vitamin B12 support erythropoiesis and cellular DNA synthesis. It is positioned for iron-deficiency nutritional support and prevention or management of iron deficiency. ([1mg.com](https://www.1mg.com/otc/lipogud-tablet-otc838440))

Brand names: Lipogud
Other names: Liposomal ferric pyrophosphate + vitamin C + cyanocobalamin + folic acid

Beyond the preview

Go deeper on Lipogud.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipogud.

Explore the full profile